Silvia Stacchiotti
S.C. Oncologia Medica 2, Tumori Mesenchimali e Rari, Fondazione IRCCS, Istituto Nazionale dei Tumori · Findazione IRCCS Istituto Nazionale Tumori Milano · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Silvia Stacchiotti as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:01 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07801222 · A Study to Assess Safety and Efficacy of SOT106 in Patients With LRRC15-positive Advanced Unresectable or Metastatic Osteosarcoma or Soft Tissue SarcomaSOTIO Biotech a.s. · not yet recruiting · Osteosarcoma Metastatic, Soft Tissue Sarcoma (STS), Osteosarcoma, Advanced · principal investigator
- Ph2NCT07328425 · Clinical Study in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT) ISG-TULIPSItalian Sarcoma Group · recruiting · Desmoplastic Small Round Cell Tumor · principal investigator
- N/ANCT06680401 · Epithelioid Haemangioendothelioma Observational StudyFondazione IRCCS Istituto Nazionale dei Tumori, Milano · recruiting · Clinical Presentation, Natural History, Treatment Outcomes · principal investigator
- Ph2NCT04305548 · Study on Trabectedin in Advanced Rearranged Mesenchymal ChondrosarcomaItalian Sarcoma Group · recruiting · Mesenchymal Chondrosarcoma · principal investigator
- Ph2NCT04274023 · Study on TSR-042 in Advanced Clear Cell SarcomaItalian Sarcoma Group · terminated · Sarcoma, Clear Cell · principal investigator
- Ph2NCT03840772 · Eribulin in Advanced Solitary Fibrous TumorItalian Sarcoma Group · completed · Solitary Fibrous Tumor · principal investigator
- Ph1/Ph2NCT03277924 · Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone SarcomasGrupo Espanol de Investigacion en Sarcomas · completed · Soft Tissue Sarcoma, Bone Sarcoma · principal investigator
- Ph2NCT03023124 · Study With Trabectedin Versus Adriamycin Plus Dacarbazine, in Patients With Advanced Solitary Fibrous TumorItalian Sarcoma Group · completed · Solitary Fibrous Tumors · principal investigator
- Ph2NCT02261207 · Phase II Study on Axitinib in Advanced Solitary Fibrous TumorFondazione IRCCS Istituto Nazionale dei Tumori, Milano · completed · Solitary Fibrous Tumor · principal investigator
- Ph2NCT02066285 · Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid ChondrosarcomaGrupo Espanol de Investigacion en Sarcomas · completed · Solitary Fibrous Tumor, Extraskeletal Myxoid Chondrosarcoma · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:01 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in osteosarcoma, ranked by citations from NIH iCite, fetched 2026-11-12 11:01 UTC. The ranking covers the 200 most relevant of 2 PubMed records, and a shared surname and initials can bring in a namesake. All 2 on PubMed
- Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group.Lancet Oncol · 201881 citationsRCR 2.7
- Nivolumab and sunitinib in patients with advanced bone sarcomas: A multicenter, single-arm, phase 2 trial.Cancer · 202530 citationsRCR 7.6